DEERFIELD MANAGEMENT COMPANY, L.P. Q3 2018 Filing
Filed November 14, 2018
Portfolio Value
$2.8T
Holdings
103
Report Date
Q3 2018
Filing Type
13F-HR
All Holdings (103 positions)
| Stock | Value |
|---|---|
—HORIZON PHARMA PLC | $129.4B |
FIXXEURHOMOLOGY MEDICINES INC | $119.5B |
—HORIZON PHARMA INVT LTD | $99.5B |
—NEVRO CORP | $99.4B |
AERIEURAERIE PHARMACEUTICALS INC | $94.8B |
—DEXCOM INC | $84.2B |
—MYLAN N V | $67.4B |
—PORTOLA PHARMACEUTICALS INC | $65.4B |
—DBV TECHNOLOGIES S A | $65.1B |
ANABANAPTYSBIO INC | $64.6B |
XLRNACCELERON PHARMA INC | $64.0B |
—ENDOCYTE INC | $62.4B |
—INTERSECT ENT INC | $61.8B |
—MYOKARDIA INC | $59.8B |
BCRXBIOCRYST PHARMACEUTICALS | $52.7B |
ACHCACADIA HEALTHCARE COMPANY IN | $50.1B |
ARGXARGENX SE | $49.8B |
—KEMPHARM INC | $48.3B |
SRPTSAREPTA THERAPEUTICS INC | $47.8B |
B7SBROOKDALE SR LIVING INC | $46.3B |
—WRIGHT MED GROUP N V | $45.6B |
ACRSACLARIS THERAPEUTICS INC | $44.9B |
CVSCVS HEALTH CORP | $44.6B |
—XERIS PHARMACEUTICALS INC | $43.9B |
2L9BLUEPRINT MEDICINES CORP | $41.0B |
MRTXEURMIRATI THERAPEUTICS INC | $39.6B |
GKOSGLAUKOS CORP | $37.0B |
EDITEDITAS MEDICINE INC | $36.9B |
—INTERCEPT PHARMACEUTICALS IN | $36.2B |
CNCCENTENE CORP DEL | $35.5B |
EHTHEHEALTH INC | $34.7B |
UHSUNIVERSAL HLTH SVCS INC | $33.5B |
—IMMUNOMEDICS INC | $33.1B |
—K2M GROUP HLDGS INC | $30.1B |
NVROEURNEVRO CORP | $29.9B |
GLPGGALAPAGOS NV | $29.2B |
SEMSELECT MED HLDGS CORP | $28.1B |
KNSAKINIKSA PHARMACEUTICALS LTD | $27.1B |
AGIOAGIOS PHARMACEUTICALS INC | $26.9B |
ELVANTHEM INC | $26.0B |
—DFB HEALTHCARE ACQUISTION CO | $25.5B |
RETAEURREATA PHARMACEUTICALS INC | $24.0B |
VCELVERICEL CORP | $22.9B |
ASNDASCENDIS PHARMA A S | $22.7B |
ARVNARVINAS INC | $20.8B |
RGNXREGENXBIO INC | $20.8B |
—AUDENTES THERAPEUTICS INC | $19.6B |
—SYNLOGIC INC | $19.4B |
FATEFATE THERAPEUTICS INC | $19.1B |
—EPIZYME INC | $18.9B |
—OXFORD IMMUNOTEC GLOBAL PLC | $17.6B |
—DIPLOMAT PHARMACY INC | $16.6B |
MOR2MORPHOSYS AG | $16.0B |
ZBHZIMMER BIOMET HLDGS INC | $15.9B |
ARDXARDELYX INC | $15.2B |
—SYROS PHARMACEUTICALS INC | $15.1B |
—AIMMUNE THERAPEUTICS INC | $15.1B |
GTHXEURG1 THERAPEUTICS INC | $15.0B |
CBAYUSDCYMABAY THERAPEUTICS INC | $14.9B |
KALVKALVISTA PHARMACEUTICALS INC | $14.4B |
SIENUSDSIENTRA INC | $14.2B |
—AAC HLDGS INC | $14.1B |
CTMXCYTOMX THERAPEUTICS INC | $13.5B |
TNDMTANDEM DIABETES CARE INC | $12.1B |
AVDLAVADEL PHARMACEUTICALS PLC | $12.0B |
NVTA1EURINVITAE CORP | $11.5B |
RYTMRHYTHM PHARMACEUTICALS INC | $10.7B |
—TELIGENT INC NEW | $10.4B |
—NIGHTSTAR THERAPEUTICS PLC | $10.2B |
ALLKGUSDALLAKOS INC | $10.1B |
—MELINTA THERAPEUTICS INC | $9.1B |
—BIOHAVEN PHARMACTL HLDG CO L | $9.0B |
—BLUEBIRD BIO INC | $9.0B |
—NUVASIVE INC | $8.9B |
LIVNLIVANOVA PLC | $8.9B |
QUREUNIQURE NV | $8.8B |
KPTIEURKARYOPHARM THERAPEUTICS INC | $8.1B |
VKTXVIKING THERAPEUTICS INC | $8.0B |
INSPINSPIRE MED SYS INC | $8.0B |
AUTLAUTOLUS THERAPEUTICS PLC | $7.7B |
—RA PHARMACEUTICALS INC | $6.9B |
RCKTROCKET PHARMACEUTICALS INC | $6.9B |
—NUVECTRA CORP | $6.1B |
—ALIMERA SCIENCES INC | $5.9B |
—PFENEX INC | $5.5B |
—GW PHARMACEUTICALS PLC | $5.1B |
ADUSADDUS HOMECARE CORP | $4.6B |
—CONSTELLATION PHARMCETICLS I | $4.3B |
—EIDOS THERAPEUTICS INC | $4.2B |
BDQMALBIREO PHARMA INC | $4.0B |
NVLSEURALPINE IMMUNE SCIENCES INC | $3.9B |
—IGI LABORATORIES INC | $3.6B |
—BIOSCRIP INC | $3.2B |
—TELIGENT INC NEW | $2.8B |
YB4PSAVARA INC | $2.8B |
—PROTEON THERAPEUTICS INC | $2.4B |
—RA MED SYS INC | $2.3B |
VYGRVOYAGER THERAPEUTICS INC | $2.2B |
KIDSORTHOPEDIATRICS CORP | $2.1B |
—FOAMIX PHARMACEUTICALS LTD | $1.3B |
Page 1 of 2Next